for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Abbott Laboratories

ABT.N

Latest Trade

109.27USD

Change

-1.62(-1.46%)

Volume

999,697

Today's Range

108.88

 - 

111.43

52 Week Range

61.62

 - 

115.14

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
110.89
Open
111.43
Volume
999,697
3M AVG Volume
120.44
Today's High
111.43
Today's Low
108.88
52 Week High
115.14
52 Week Low
61.62
Shares Out (MIL)
1,772.36
Market Cap (MIL)
196,537.20
Forward P/E
31.20
Dividend (Yield %)
1.30

Next Event

Q4 2020 Abbott Laboratories Earnings Release

Latest Developments

More

Abbott Laboratories Launches First Infant Formula In Canada With An Ingredient Identical In Structure To Immune Component Found In Breast Milk

Abbott Reports Third-Quarter 2020 Results Achieves Strong Double-Digit Earnings Growth And Raises Guidance

Abbott Reports Q3 Adjusted Eps $0.98 From Continuing Operations

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.

Industry

Medical Equipment & Supplies

Contact Info

100 Abbott Park Rd

ABBOTT PARK, IL

60064-3500

United States

+1.224.6676100

https://www.abbott.com

Executive Leadership

Miles D. White

Executive Chairman of the Board

Robert B. Ford

President, Chief Executive Officer, Director

Robert E. Funck

Chief Financial Officer, Executive Vice President - Finance

Hubert L. Allen

Executive Vice President, General Counsel, Secretary

Mary K. Moreland

Executive Vice President of Human Resources

Key Stats

1.90 mean rating - 21 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

27.4K

2018

30.6K

2019

31.9K

2020(E)

33.9K
EPS (USD)

2017

2.500

2018

2.880

2019

3.240

2020(E)

3.554
Price To Earnings (TTM)
58.99
Price To Sales (TTM)
6.10
Price To Book (MRQ)
6.26
Price To Cash Flow (TTM)
29.91
Total Debt To Equity (MRQ)
59.14
LT Debt To Equity (MRQ)
58.46
Return on Investment (TTM)
5.76
Return on Equity (TTM)
4.88

Latest News

Latest News

U.S. government to send out over 7 million Abbott BinaxNOW tests this week

The U.S. government will send over 7 million of Abbott Laboratories' BinaxNOW rapid antigen tests for COVID-19 to states, hospice providers, and for other uses this week, a top administration official said at a press briefing on Monday.

BRIEF-HHS Official Says The Agency Has Responded To Every State That Has Requested "Surge Sites" For Covid-19 Testing - Press Call

* HHS' BRETT GIROIR SAYS WILL BE SENDING OVER 8 MILLION OF ABBOTT'S BINAXNOW TESTS TO THE STOCKPILE THIS WEEK - PRESS CALL

Breakingviews - Test giants have problems but a vaccine ain’t one

Diagnostic giants could be the pandemic’s big winners. News that Pfizer’s Covid-19 vaccine may work dealt a blow to shares of Abbott Laboratories and Roche. Yet a likely slow rollout, and opposition to inoculation mean they needn’t panic. The real challenge is likely to...

United to give travelers free COVID-19 tests on select Newark-London flights

United Airlines said on Thursday it will offer free rapid COVID-19 tests to customers on select transatlantic flights, as part of a four-week pilot program aimed at eventually relaxing quarantines that have crippled air travel.

Quest raises profit forecast as COVID-19 tests demand to jump

Quest Diagnostics Inc <DGX.N> raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.

Breakingviews - Corona Capital: U.S. tests, UK loans, Man U groans

Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Abbott says COVID-19 test demand to grow in 2021

Abbott Laboratories <ABT.N> said it expects demand for its COVID-19 tests to grow in 2021 even if a vaccine is developed and for the business to eventually stabilize into a lucrative new franchise.

Abbott quarterly profit rises 28.3% on strong sales of COVID-19 tests

Abbott Laboratories posted a 28.3% rise in third-quarter profit on Wednesday, helped by strong sales of COVID-19 tests and strength in its nutrition and diabetes businesses.

Trump tests negative for COVID-19, is not infectious: White House physician

U.S. President Donald Trump has tested negative for COVID-19 and he is not infectious to others, the White House physician said on Monday, 10 days after Trump announced he had contracted the coronavirus.

Abbott wins U.S. emergency use authorization for new COVID-19 antibody test

Abbott Laboratories said on Monday the U.S. Food and Drug Administration has issued an emergency use authorization for its lab-based COVID-19 antibody blood test.

Abbott says new data shows rapid COVID-19 test used at White House is highly accurate

Abbott Laboratories on Wednesday released early data from a study on the accuracy of its ID NOW COVID-19 test, which is used in the White House, that could help alleviate concerns the diagnostic frequently fails to detect the virus.

Abbott says ID NOW COVID-19 rapid test shows high sensitivity in study

Abbott Laboratories said on Wednesday its ID NOW COVID-19 rapid test showed 96.2% sensitivity and 99.5% specificity compared to lab-based molecular PCR tests, according to interim data from a study.

Relying on testing to ward off COVID put Trump White House at risk

Early in the coronavirus pandemic, U.S. President Donald Trump put his faith in a toaster-sized machine that could spit out test results in a matter of minutes.

INSIGHT-Relying on testing to ward off COVID put Trump White House at risk

Early in the coronavirus pandemic, U.S. President Donald Trump put his faith in a toaster-sized machine that could spit out test results in a matter of minutes.

Abbott wins EU approval for smallest version of glucose monitoring device

Abbott Laboratories' <ABT.N> said on Monday it had received clearance to market the smallest version of its fastest-growing low-cost diabetes monitoring product in the European Union.

U.S. to send millions of rapid COVID-19 tests to states to support school reopening, other tasks

The U.S. government will send an "overwhelming majority" of the rapid COVID-19 tests it purchased from Abbott Laboratories last week to governors of states and territories to support school reopenings and other critical tasks, an administration official said at a press briefing...

UPDATE 1-U.S. to send millions of rapid COVID-19 tests to states to support school reopening, other tasks

The U.S. government will send an "overwhelming majority" of the rapid COVID-19 tests it purchased from Abbott Laboratories last week to governors of states and territories to support school reopenings and other critical tasks, an administration official said at a press briefing...

U.S. to send millions of rapid COVID-19 tests to states to support school reopening, other tasks

The U.S. government will send an "overwhelming majority" of the rapid COVID-19 tests it purchased from Abbott Laboratories last week to governors of U.S. states and territories to support school reopening and other critical tasks, an administration official said at a press...

Breakingviews - Corona Capital: Abbott’s test, Dollar General

Corona Capital is a daily column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Trump administration to purchase 150 million Abbott COVID-19 tests for $750 million

The Trump administration will purchase 150 million rapid coronavirus tests from Abbott Laboratories <ABT.N> for about $750 million, a White House spokeswoman said on Thursday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up